From: Unraveling the site-specific features in small intestinal stromal tumors: a retrospective study
Variables | Duodenum# | Jejunum# | Ileum# | P value | P value Between groups |
---|---|---|---|---|---|
Diameter of tumor | 3.8 (2.6, 5.4) | 5.5 (3.1, 8.0) | 7.5 (5.2, 10.0) | <0.001* | Duodenum vs. Jejunum <0.001* Jejunum vs. Ileum 0.005* Duodenum vs. Ileum<0.001* |
c-KIT (CD117) | Positive: 111 (100%) | Negative: 2 (2%) Partial positive: 2 (2%) Positive: 106 (96%) | Negative: 2 (2%) Partially positive: 2 (2%) Positive: 84 (96%) | 0.205 | / |
DOG-1 | Positive: 110 (100%) | Negative: 1 (1%) Positive: 105 (99%) | Negative: 3 (3%) Partially positive: 5 (6%) Positive: 79 (91%) | <0.001* | Duodenum vs. Jejunum 0.491 Jejunum vs. Ileum 0.008* Duodenum vs. Ileum 0.001* |
CD34 | Negative: 15 (13%) Partially positive: 19 (17%) Vascular positive: 19 (17%) Positive: 58 (52%) | Negative: 13 (12%) Partially positive: 23 (21%) Vascular positive: 21 (19%) Positive: 52 (48%) | Negative: 13 (15%) Partially positive: 13 (15%) Vascular positive: 17 (19%) Positive: 45 (51%) | 0.933 | / |
Ki-67 | <5%: 68 (62%) ≥ 5%: 41 (38%) | <5%: 57 (52%) ≥ 5%: 53 (48%) | <5%: 36 (41%) ≥ 5%: 51 (59%) | 0.013* | Duodenum vs. Jejunum 0.134 Jejunum vs. Ileum 0.154 Duodenum vs. Ileum 0.004* |
SDHB | Negative: 6 (9%) Partially positive: 4 (6%) Positive: 59 (86%) | Negative: 1 (2%) Partially positive: 2 (3%) Positive: 57 (95%) | Negative: 2 (5%) Partially positive: 1 (3%) Positive: 34 (92%) | 0.406 | / |
SMA | Negative: 38 (34%) Partially positive: 26 (23%) Vascular positive: 1 (1%) Positive: 46 (41%) | Negative: 38 (35%) Partially positive: 21 (19%) Vascular positive: 1 (1%) Positive: 50 (46%) | Negative: 23 (27%) Partially positive: 21 (26%) Vascular positive: 3 (4%) Positive: 36 (43%) | 0.616 | / |
S-100 | Negative: 94 (85%) Partially positive: 13 (12%) Neural positive: 1 (1%) Positive: 3 (3%) | Negative: 96 (87%) Partially positive: 10 (9%) Positive: 4 (4%) | Negative: 70 (81%) Partially positive: 11 (13%) Positive: 5 (6%) | 0.749 | / |
Desmin | Negative: 106 (97%) Partially positive: 2 (2%) Positive: 1 (1%) | Negative: 101 (95%) Partially positive: 4 (4%) Positive: 1 (1%) | Negative: 81 (95%) Partially positive: 3 (4%) Positive: 1 (1%) | 0.933 | / |
Mitotic count /50HPF | 2.0 (1.0, 4.5) | 3.0 (1.5, 7.5) | 5.0 (2.0, 10.0) | 0.002* | Duodenum vs. Jejunum 0.163 Jejunum vs. Ileum 0.316 Duodenum vs. Ileum 0.002* |
T category | T1: 11 (9.8%) T2: 71 (63.4%) T3: 28 (25.0%) T4: 2 (1.8%) | T1: 9 (8.0%) T2: 41 (36.3%) T3: 45 (39.8%) T4: 18 (15.9%) | T1: 3 (3.3%) T2: 19 (20.7%) T3: 49 (53.3%) T4: 21 (22.8%) | <0.001* | Duodenum vs. Jejunum<0.001* Jejunum vs. Ileum 0.024 Duodenum vs. Ileum<0.001* |
N category | N0: 111 (99.1%) N1: 1 (0.9%) | N0: 113 (100.0%) N1: 0 (0%) | N0: 92 (100%) N1: 0 (0%) | 0.644 | / |
M category | M0: 109 (97.3%) M1: 3 (2.7%) | M0: 105 (92.9%) M1: 8 (7.1%) | M0: 81 (88.0%) M1: 11 (12.0%) | 0.034* | Duodenum vs. Jejunum 0.126 Jejunum vs. Ileum 0.231 Duodenum vs. Ileum 0.009* |
Risk category | Very low risk: 9 (8.0%) Low risk: 59 (52.7%) Intermediate risk: 9 (8.0%) High risk: 35 (31.3%) | Very low risk: 7 (6.2%) Low risk: 40 (35.4%) Intermediate risk: 4 (3.5%) High risk: 62 (54.9%) | Very low risk: 1 (1.1%) Low risk: 12 (13.0%) Intermediate risk: 5 (5.4%) High risk: 74 (80.4%) | <0.001* | Duodenum vs. Jejunum 0.004* Jejunum vs. Ileum<0.001* Duodenum vs. Ileum<0.001* |